Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS)

worldpharmanewsNovember 10, 2020

Tag: Novartis , CAN-COVID , canakinumab , COVID-19

PharmaSources Customer Service